梅州哪面部线雕好(梅州怎么样诊治念珠菌性阴道炎) (今日更新中)

Alex Shkop, the owner of Guns and Range Training Center in West Palm Beach, says the current ammunition shortage could continue for awhile. 147

Abby and I wish a heart-felt congratulations to @JoeBiden and @KamalaHarris on the election call today. Thank you for your commitment to unite us all. We pray for you and promise to work with you to benefit the people of Utah. 1/— Spencer Cox (@SpencerJCox) November 7, 2020 282

After struggling to ramp up coronavirus testing, the U.S. can now screen several million people daily, thanks to a growing supply of rapid tests. But the boom comes with a new challenge: keeping track of the results.All U.S. testing sites are legally required to report their results, positive and negative, to public health agencies. But state health officials say many rapid tests are going unreported, which means some new COVID-19 infections may not be counted.And the situation could get worse, experts say. The federal government is shipping more than 100 million of the newest rapid tests to states for use in public schools, assisted living centers and other new testing sites.“Schools certainly don’t have the capacity to report these tests,” said Dr. Jeffrey Engel of the Council of State and Territorial Epidemiologists. “If it’s done at all it’s likely going to be paper-based, very slow and incomplete.”Early in the outbreak, nearly all U.S. testing relied on genetic tests that could only be developed at high-tech laboratories. Even under the best circumstances, people had to wait about two to three days to get results. Experts pushed for more “point-of-care” rapid testing that could be done in doctors offices, clinics and other sites to quickly find people who are infected, get them into quarantine and stop the spread.Beginning in the summer, cheaper, 15-minute tests — which detect viral proteins called antigens on a nasal swab — became available. The first versions still needed to be processed using portable readers. The millions of new tests from Abbott Laboratories now going out to states are even easier to use: they’re about the size of a credit card and can be developed with a few drops of chemical solution.Federal health officials say about half of the nation’s daily testing capacity now consists of rapid tests.Large hospitals and laboratories electronically feed their results to state health departments, but there is no standardized way to report the rapid tests that are often done elsewhere. And state officials have often been unable to track where these tests are being shipped and whether results are being reported.In Minnesota, officials created a special team to try and get more testing data from nursing homes, schools and other newer testing sites, only to be deluged by faxes and paper files.“It’s definitely a challenge because now we have to do many more things manually than we were with electronic reporting,” said Kristen Ehresmann, of the Minnesota Department of Health.Even before Abbott’s newest BinaxNOW rapid tests hit the market last month, undercounting was a concern.Competitors Quidel and Becton Dickinson have together shipped well over 35 million of their own quick tests since June. But that massive influx of tests hasn’t showed up in national testing numbers, which have mostly ranged between 750,000 and 950,000 daily tests for months.Besides tallying new cases, COVID-19 testing numbers are used to calculate a key metric on the outbreak: the percentage of tests positive for COVID-19. The World Health Organization recommends countries test enough people to drive their percent of positives below 5%. And the U.S. has mostly been hovering around or below that rate since mid-September, a point that President Donald Trump and his top aides have touted to argue that the nation has turned the corner on the outbreak. The figure is down from a peak of 22% in April.But some disease-tracking specialists are skeptical. Engel said his group’s members think they aren’t getting all the results.“So it may be a false conclusion,” he said.One of the challenges to an accurate count: States have wildly different approaches. Some states lump all types of tests together in one report, some don’t tabulate the quick antigen tests at all and others don’t publicize their system. Because antigen tests are more prone to false negatives and sometimes require retesting, most health experts say they should be recorded and analyzed separately. But currently the vast majority of states do not do that and post the results online.The federal government is allocating the tests to states based on their population, rather than helping them develop a strategy based on the size and severity of their outbreaks.“That’s just lazy” said Dr. Michael Mina of Harvard University. “Most states won’t have the expertise to figure out how to use these most appropriately.”Instead, Mina said the federal government should direct the limited test supplies to key hot spots around the country, driving down infections in the hardest-hit communities. Keeping tighter control would also ensure test results are quickly reported.Johns Hopkins University researcher Gigi Gronvall agrees health officials need to carefully consider where and when to deploy the tests. Eventually, methods for tracking the tests will catch up, she said.“I think having the tools to determine if someone is infectious is a higher priority,” she said.___AP data journalist Nicky Forster contributed to this story___Follow Matthew Perrone on Twitter: @AP_FDAwriter___The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content. 5285

A woman claims she suffered a small cut on her finger from the nail salon she's been going to for more than a decade. Two weeks later, she found herself in the hospital having surgery due to a major infection, and there's a chance she may have to have her finger amputated. The image of Maria Luisa Gerardo's finger is extremely graphic — a wound that goes all the way down to the bone. "I cover my face when they come in here and take (the bandage) off because I don't wanna see it," said Gerardo. "I don't. I'm scared."Gerardo made her regular visit to TJ Nails, a place she's been going to for more than a decade, where they call her "Mama." But two weeks ago she claims she received a small cut on her finger. "A little open wound, here on the side of my finger," said Gerardo.A day later, her finger started swelling. Gerardo went to Urgent Care, where they put her on antibiotics.She went back to the nail salon, and she says they offered her 0."He told me, 'It's nothing. Just clean your hand and buy your medicine, and it will come off," said Gerardo. But it only got worse, and Gerardo had to go into surgery."Pretty excruciating to see," said Gerardo's son Victor. "I don't like to see my mom in pain."Victor was by his mom's side during the surgery and days following. "He cleaned as much as he could, to try and salvage the finger," said Victor. "He told me, he kept cutting and cutting the tissue around her finger until it bled, because that was good skin."Gerardo says a man named Bill was the technician who cut her nails that day. Employees at TJ Nails claim he no longer works at the salon and recently moved out of state.Bill said in a phone interview that he never cut Gerardo's nails and he knew her very well and did nothing wrong. Meantime, Gerardo is looking for answers and waiting to see if she will be able to keep her finger. "This is the only thing I ever liked doing to myself, my nails," said Gerardo. "But now, with this that happened to my hand, I never want to do this in my life."The family reported TJ Nails to the state. They are planning on working with a lawyer to take legal action against the salon.  2212

A pharmaceutical that has already issued a recall for dozens of children's medications is expanding its recall to include more than a thousand additional medications for both humans and animals.The FDA reported earlier this month that King Bio had issued a voluntary recall for about 30 children's medications for a possible microbial contamination. Now, the company is expanding the recall to include more than 1,200 medications for adults, as well as medicine used by vets and pet owners.According to the FDA, King Bio still has not yet received any reports of illness from contaminated medicine. According to the FDA, the use of the drugs could potentially result in increased infections.Customers currently in possession of affected product should discontinue its use immediately and contact King Bio by email or call the company at 866-298-2740. The company also says it is notifying distributors and customers by letter.Below is a list of the contaminated medications. For more information on King BIo's children's medication recall, click here.ADULT MEDICATIONS 1106

来源：资阳报